Condition
Recurrent Malignant Female Reproductive System Neoplasm clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Recurrent Malignant Female Reproductive System Neoplasm clinical trials that are recruiting, at sites in 2 countries (most in Puerto Rico (2), United States (2)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Testing neratinib alone or with palbociclib for HER2 positive solid tumors
This study is testing if a new cancer treatment called neratinib works better alone or with another drug, palbociclib, for people with HER2 positive solid tumors, especially those with gynecologic cancers.
-
Targeted therapy for advanced solid tumors based on genetic testing
This study is testing whether matching patients with advanced solid tumors to specific treatments based on their genetic makeup can improve their outcomes when standard options have failed.
Related topics
Quick answers
How many Recurrent Malignant Female Reproductive System Neoplasm clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Puerto Rico (2 trials), United States (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.